Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications

Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications

Alzheimer’s disease (AD) affects over 6 million people over the age of 65. The advent of new anti-amyloid monoclonal antibodies as treatment for early Alzheimer’s disease these immunotherapeutics may slow disease progression but also pose significant risks. Amyloid related imaging abnormalities (ARI...

Full description

Bibliographic Details
Main Authors: Sarah J. Doran, Russell P. Sawyer
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Neuroscience
Subjects:
ARIA-E
ARIA-H
Alzheimer’s disease
anti-amyloid
Apoε4
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2024.1326784/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2024.1326784/full

Similar Items